Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jacques Gonella currently holds 9,385,848 shares of ANTARES PHARMA, INC. (AIS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jacques Gonella has been a net seller of AIS stock. They have purchased $72.0K and sold $7.8M worth of shares.
Jacques Gonella's most recent insider trade was on Feb 26, 2019, when they sold 200,000 shares at $3.65 per share.
Jacques Gonella serves as Executive at ANTARES PHARMA, INC. (AIS). They have executed 49 insider transactions totaling $7.8M over their tenure at the company.
Jacques Gonella holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Jacques Gonella has shown a selling trading pattern, with $72.0K in total purchases and $7.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jacques Gonella was on Oct 2, 2018, when they sold $1.5M worth of ATRS shares. This transaction involved 400,000 shares at $3.79 per share.
Jacques Gonella currently owns 9,385,848 shares of ANTARES PHARMA, INC. (AIS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jacques Gonella's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jacques Gonella has 49 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Jacques Gonella and 40,000+ other insiders.